In theory, this supports fat loss and body recomposition
The pilot program is not for beneficiaries with type 2 diabetes, obstructive sleep apnea or MASH. Those enrollees and those prescribed GLP-1s to reduce the risk of heart attack, stroke or coronary bypass surgery are ineligible for the program and can get Medicare coverage of the drugs only through their Part D plan, CMS says
Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study
In fact, studies show that GLP-1 receptor agonists may help people maintain an average weight loss of up to 17% of their initial body weight (Rubino, 2021)
Food and Drug Administration (FDA), for the following conditions: Type 2 Diabetes: Semaglutide helps people with type 2 diabetes improve their blood sugar levels